Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 3, 2006, Pages

  Versteilen, Amanda M G ^a,b   Korstjens, Iolente J M ^a   Musters, René J P ^a   Groeneveld, A B Johan ^a   Sipkema, Pieter ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute renal failure; Nitric oxide synthase 3; ROCK; Vascular reactivity; Vasodilator stimulated phosphoprotein

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MICROSPHERE; NITRIC OXIDE; PHOSPHOPROTEIN; RHO KINASE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CLAMP; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; FLUORESCENCE ANALYSIS; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; REPERFUSION; VASODILATATION;

EID: 33748439110     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00434.2005     Document Type: Article

References (25)

1. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, and Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55: 1078-1087, 1999.
2. Caron A, Desrosiers RR, and Béliveau R. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, β-actin and rho GTPases in proximal tubules. Arch Biochem Biophys 431: 31-46, 2004.
3. Conger JD, Robinette JB, and Hammond WS. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 39: 1087-1097, 1991.
4. Conger JD and Weil JV. Abnormal vascular function following ischemia-reperfusion injury. J Invest Med 43: 431-442, 1995.
5. Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z, and Luscher TF. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res 89: 583-590, 2001.
6. Goligorsky MS, Brodsky SV, and Noiri E. NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin Nephrol 24: 316-323, 2004.
7. 2+ sensitivity in vascular smooth muscle. J Smooth Muscle Res 40: 210-236, 2004.
8. Ikeda F, Terajima H, Shimahara Y, Kondo T, and Yamaoka Y. Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632. J Surg Res 109: 155-160, 2003.
9. Ishimura T, Fujisawa M, Isotani S, Iijima K, Yoshikawa N, and Kamidono S. Endothelial nitric oxide synthase expression in ischemia-reperfusion injury after living related-donor renal transplantation. Transpl Int 15: 635-640, 2002.
10. Korstjens IJ, Smolders RG, van der Mooren MJ, Kloosterboer HJ, Kenemans P, and Sipkema P. Endothelium-dependent dilatory effects of 3α-OH-tibolone in gracilis muscle arterioles of the female Wistar rat. Menopause 12: 340-347, 2005.
11. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Bohm M, Schoen FJ, Moskowitz MA, and Liao JK. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106: 15-24, 2000.
12. Luo Z, Fujio Y, Kureishi Y, Rudic RD, Daumerie G, Fulton D, Sessa WC, and Walsh K. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest 106: 493-499, 2000.
13. Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, and Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22: 8467-8477, 2002.
14. Molitoris BA and Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 66: 496-499, 2004.
15. Munzel T, Feil R, Mulsch A, Lohmann SM, Hofmann F, and Walter U. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. Circulation 108: 2172-2183, 2003.
16. Nijveldt RJ, Prins HA, van Kemenade FJ, Teerlink T, van Lambalgen AA, Boelens PG, Rauwerda JA, and van Leeuwen PA. Low arginine plasma levels do not aggravate renal blood flow after experimental renal ischaemia/reperfusion. Eur J Vasc Endovasc Surg 22: 232-239, 2001.
17. Raab S, Thein E, Harris AG, and Messmer K. A new sample-processing unit for the fluorescent microsphere method. Am J Physiol Heart Circ Physiol 276: H1801-H1806, 1999.
18. Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmuller S, Walter U, Reichenspurner H, Meinertz T, and Munzel T. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 105: 1170-1175, 2002.
19. Shimokawa H and Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 25: 1767-1775, 2005.
20. Takemoto M, Sun J, Hiroki J, Shimokawa H, and Liao JK. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106: 57-62, 2002.
21. Teraishi K, Kurata H, Nakajima A, Takaoka M, and Matsumura Y. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion- induced acute renal failure in rats. Eur J Pharmacol 505: 205-211, 2004.
22. Van Nieuw Amerongen GP and van Hinsbergh VWM. Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol 21: 300-311, 2001.
23. Van Nieuw Amerongen GP, Koolwijk P, Versteilen A, and van Hinsbergh VWM. Involvement of RhoA/Rho kinase in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 23: 211-217, 2003.
24. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, and Liao JK. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24: 1842-1847, 2004.
25. Yamasowa H, Shimizu S, Inoue T, Takaoka M, and Matsumura Y. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 312: 153-159, 2005.